Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance.
about
Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects.Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.Acylation stimulating protein, complement C3 and lipid metabolism in ketosis-prone diabetic subjects.Relationship of C5L2 receptor to skeletal muscle substrate utilization.Acute effects of exogenous hormone administration on postprandial acylation stimulating protein levels in ovariectomized rats after a fat load.Protective role for properdin in progression of experimental murine atherosclerosis.Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics.Regulation of postprandial lipemia: an update on current trends.Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.Paradoxical glucose-sensitizing yet proinflammatory effects of acute ASP administration in mice.Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomesPlasma gamma-glutamyltransferase is strongly determined by acylation stimulating protein levels independent of insulin resistance in patients with acute coronary syndrome.Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women.Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.Plasma Levels of Acylation-Stimulating Protein Are Strongly Predicted by Waist/Hip Ratio and Correlate with Decreased LDL Size in Men.Acylation stimulating protein: a female lipogenic factor?Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes.The role of complement system in adipose tissue-related inflammation.Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance.Dietary and flight energetic adaptations in a salivary gland transcriptome of an insectivorous bat.Targeting the signaling pathway of acylation stimulating protein.Acylation stimulating protein is higher in Inuit from Nunavik compared to a southern Quebec population.Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.Increased acylation stimulating protein levels in young obese males is correlated with systemic markers of oxidative stress.Cross-sectional associations of acylation stimulating protein (ASP) and adipose tissue gene expression with estradiol and progesterone in pre- and postmenopausal women.Acylation-stimulating protein: effect of acute exercise and endurance training.Adiposopathy: why do adiposity and obesity cause metabolic disease?
P2860
Q25257210-F4767BC5-433A-4403-8C58-7E9AFCF308CAQ30384917-0ACB1C45-96BF-4979-9FCE-E9220BEB90A0Q34282344-1A98B9FA-BBFD-4108-BD86-F47A48F6EAB4Q34608628-48292197-2721-4995-BD3F-B900EF66556FQ34708229-C52C0B63-7E96-4AD9-95D5-161F7AD29C73Q35131403-B975AA0A-B02F-4A4D-95ED-C95DC1EF3281Q35808559-39107EF6-A67F-456E-9B4A-AE2D1DBD38E6Q36749246-E3FE4459-A35A-4ED1-ADCA-003CB29159FFQ36814772-8B589974-01FC-4332-A59F-5C59859A066FQ36882808-C9CECBD4-7CA2-43EE-8020-E800DE153FBFQ37067258-6BC285CB-A9B2-43B3-89F0-DF59F645C274Q37176656-CC7F9490-94DC-4016-8A4C-33E0E18B123FQ37184230-9BE0D37B-E51D-4756-9A77-DB5B15FBF4E0Q37190372-FEDA9369-A87F-42E0-8401-C88F363B6712Q37215478-4145015A-5264-4B65-9EC1-C5CC0ECD45C8Q37515367-CC051372-D319-44F3-875F-D3AA415CBFD8Q37846807-5B3C7D43-9855-4635-A8B1-130449214F32Q38294970-7022E940-71F3-4480-9B4A-952704A8C233Q38318585-173292D3-7C3D-4D41-ADD9-3899870FDB17Q38692815-C3FAC633-C39D-47C4-9EBE-6967AD8D7200Q40090989-8F22351B-7E4B-412E-9A6D-79A7B98A7855Q40140325-B74BEEDC-2CCA-4F08-BDF4-10A403C582CCQ41871399-AA32771A-68B5-48B8-8B2E-07807A4AC7D7Q42487513-E112A74E-359E-4F8C-AAA8-9C5EEF09AF7EQ43203617-DC01770B-8FAE-453B-B6B0-BA0799806C59Q46853706-7BA4BA92-FFF8-4CA1-A3C9-4CC2906B9A2DQ50999771-9C57DD95-B8D3-4A2F-B926-BD108C68049AQ51318747-6ECFEC1E-069C-42F5-A4D9-12E04F94110EQ51519198-EA67D172-A97A-4640-9285-C5E3FF51F230Q56567724-CD3BA3EA-A845-46C5-94BB-8714CB87C077
P2860
Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Fasting acylation-stimulating ...... andial triglyceride clearance.
@en
Fasting acylation-stimulating ...... andial triglyceride clearance.
@nl
type
label
Fasting acylation-stimulating ...... andial triglyceride clearance.
@en
Fasting acylation-stimulating ...... andial triglyceride clearance.
@nl
prefLabel
Fasting acylation-stimulating ...... andial triglyceride clearance.
@en
Fasting acylation-stimulating ...... andial triglyceride clearance.
@nl
P2093
P2860
P1476
Fasting acylation-stimulating ...... andial triglyceride clearance.
@en
P2093
Allan Sniderman
Bernadette Delplanque
Charles Couillard
Jean-Pierre Despres
Robert Zakarian
P2860
P304
P356
10.1194/JLR.M300214-JLR200
P577
2003-10-16T00:00:00Z